Summary:
- This article discusses a new cancer therapy that has shown promising results in treating a type of incurable leukemia called acute lymphoblastic leukemia (ALL).
- The therapy involves genetically modifying a patient's own immune cells (T cells) to recognize and attack the cancer cells, a process known as CAR-T cell therapy.
- In an early clinical trial, the new CAR-T cell therapy was able to put 93% of patients with relapsed or treatment-resistant ALL into remission, offering hope for those with this previously incurable form of blood cancer.